-
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from Analysts
Source: Buzz FX / 22 Feb 2025 03:26:13 America/Chicago
Cardiol Therapeutics Inc. (NASDAQ:CRDL) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 22, 2025 Share Link copied to clipboard. Cardiol Therapeutics Inc. ( NASDAQ:CRDL - Get Free Report ) has been given an ave
Read more...